Mid-cycle EBITDA raised to $2.9B, $3.3B by 2030
Guidance tone
CF Industries reported strong first-half 2026 results, driven by a tight nitrogen market and high utilization rates. Management raised its mid-cycle EBITDA outlook, citing structurally higher capital costs for new capacity and sustained geopolitical risk, and reaffirmed its long-term growth with Bluepoint and a potential new DEF plant. FY2026 first-half adjusted EBITDA was $2.2 billion, with strong operational performance (98% asset utilization).
CF Industries reported strong first-half 2026 results, driven by a tight nitrogen market and high utilization rates. Management raised its mid-cycle EBITDA outlook, citing structurally higher capital costs for new capacity and sustained geopolitical risk, and reaffirmed its long-term growth with Bluepoint and a potential new DEF plant. FY2026 first-half adjusted EBITDA was $2.2 billion, with strong operational performance (98% asset utilization).
Guidance tone
Reported gross margin was 51.53%, reinforcing the quarter's better-than-guided profitability.
Mid-cycle EBITDA baseline raised to ~$2.9B, with an expectation to reach ~$3.3B by 2030, excluding geopolitical premiums.
Demand was strong in North America for ammonia and urea in H1, with a pause in June. UAN fill programs in July built a substantial order book extending into November, and fall ammonia season is expected to be strong. Global demand is deferred, not lost, with India expected to…
Demand was strong in North America for ammonia and urea in H1, with a pause in June. UAN fill programs in July built a substantial order book extending into November, and fall ammonia season is expected to be strong. Global demand is deferred, not lost, with India expected to import 9-10 million tons.
Management is investing in strategic projects including Bluepoint (ammonia) and a potential DEF unit at Courtright, with 2026 capex projected at about $1.3 billion total ($950 million CF share). They are disciplined on capital allocation, prioritizing high-return projects and share repurchases.
Management expressed confidence in the structural tightening of the nitrogen market, raised mid-cycle EBITDA expectations, and highlighted the company's undervaluation and strong cash generation.
Removing permitting delays clears the path to execution of a major growth project.
“At Bluepoint, We have received all necessary permits to begin construction.”
Potential schedule delays are mitigated by early orders, but could affect other capacity additions industry-wide.
“you are seeing procurement timelines extend some and that was primarily for electrical gear”
Temporary loss of capacity is covered by insurance and contributes to tight market conditions.
“we expect our Yazoo City complex to resume operations in the first half of 2027”
“As you look at that price going from $355 to $385, the underlying assumptions that we have is this is for a 1.3 to 1.4 million ton capacity site with a capex estimate of about $2.6 to $2.8 billion.”
“As you look at Yazoo City, the urea plant there would have to be a full-blown new urea plant, world-scale plant there. And we look at what we have opportunity-wise that Bert's commercial team has put together.”
“The one thing I would add is this isn't really our thoughts on the growth of DF in isolation. Essentially, we've worked with OEM engine manufacturers all the way down to the retail side to make certain that we're aligned as to the growth t…”
| 지표 | 기간 | 범위 | 중간값 | 상태 |
|---|---|---|---|---|
| Capex | FY2026 | $1.3B | $1.3B | MAINTAINED |
CF's partnership with Linde on the Bluepoint CCS unit is a cost mitigation strategy; reaffirms Linde's role in major industrial gas projects.
“We did that a couple different ways. One was through our partnerships where we partnered with Lindy and even Oxy's 1.5 on the CCS unit.”
Yeah.
Well, what I was going to say is essentially when we looked at the Bluepoint project, the one thing we tried to do was mitigate our overall costs related to that. We did that a couple different ways. One was through our partnerships where we partnered with Lindy and even Oxy's 1.5 on the CCS unit. but additionally even with Mitsui and Jera where they're providing some insight and administrative benefits along with as we go to the module yards in Asia. So I think that is one area where we look to lock down on some of those costs. What we have fixed is roughly probably about 50% of the CapEx related to that and that is in a couple different areas. One is in the engineering and the module yards. The other is in some of the lump sum turnkeys that we try to do on the infrastructure pieces, whether it be the tank or some of the dock and bridge work and things like that. So we feel pretty confident about how we're managing through this. As I mentioned earlier, we have our long lead items for Bluepoint purchase. So some of those things that we're seeing with extension of lead times or increases in costs related to those, We started some of those critical items, having contracts in place even pre-FID on the project itself.
CF's partnership with Jera is a key off-take agreement for Bluepoint's low-carbon ammonia, providing a committed revenue stream for the project.
Chris, I'd love to hear your perspective on just kind of your intermediate, longer-term outlook. It also seems like the demand side of it's been a little bit more quiet versus some positive events back in 25. I'd love to just hear your dynamics in terms of market development, your position, how you're thinking about the overall Blue Point complex and any incremental opportunities you see fit based on the fact that a lot of others have given up. Thank you so much.
I think to start with, Chris, the ones that have given up are participants that were not necessarily in the market to begin with. If we go back a few years ago, I've said this before, there was like 107 green and blue plants announced, of which I think there's four in construction today, of which ours is one of them. So there is a lot of hype about what clean energy was going to be. Our analysis never showed more than we were thinking maybe seven of that 107 would be built. So I think we've been more pragmatic in this. As you look at that clean energy market, it's really similar to the DEF market that Bert mentioned. The million tons that will be going both to Jera and Mitsui, our partners, is a million tons of incremental demand that didn't exist just a few years ago. We're continuing to see some growth opportunities in Japan and other pieces of Asia, but it's going to be at a slower pace than what I think the original hype was on that. What benefits us is whether we have a low-carbon ton or a conventional ton, we produce it the same way, we store it the same way, we transport it the same way. So all those operational efficiencies that we have as an organization to lower our costs per ton on new construction and also the distribution of it reside with us and accrue to us that others don't have. And I think that's why you're seeing us continue to be bullish on both Bluepoint and maybe even a Bluepoint 2 is because of those assets and really that ability we have to move that product and to produce that product.
CF's arrangement with Exxon for CO2 transport and storage is in place, with the economics set to improve once the Class VI permit is approved.
And then I just wanted to sanity check something regarding 45Q. So when I look at Q1, there is 19 million of 45Q income, which if I sort of divide it by the $85 a ton CO2 price, gives me a CO2 capture of slightly more than 200,000 tons. and as far as we know, Donaldsonville is around 500,000 tons CO2 per quarter. Is that calculation missing something or is Donaldsonville CO2 still ramping up?
Well, I think there's two points there. One, the revenue through the first half of the year is about $45 million associated with the 45Q, not the number that you suggested. The second part is this year we do expect The overall CO2 to be lower throughout the Donaldsonville facility primarily because of the turnarounds that took place there. I mentioned earlier ammonia 6, which is effectively two ammonia plants with its production, went through a turnaround. It's completed that turnaround now, but that turnaround began in June and went through July as well. So as a result of that, you're going to have lower CO2 that was available in order to sequester during that time frame. but I think the numbers themselves which show through in the other operating income line are correct at 45 million and the one thing I would mention is that we are not taking it to a class six as of right now and so as that is at $60 per ton We do believe, just to maybe follow up on that, that the Class 6 approval will be happening later this year, and then that will move to the $85 a ton. Economically, we're indifferent because our transfer today is at a zero cost with Exxon, and it will move up to the contractual rate once the Class 6 is in place.
Yara's acquisition of the Gulf Coast ammonia plant will likely redirect its output to Europe, impacting global ammonia trade flows and potentially boosting Yara's feedstock security.
Hi, all. This is Rahi on for Ben. Maybe on S&D, are you seeing any impacts on the extra Texas capacity this year, like Gulf Coast, Monia, Woodside, or is this just largely offsetting Trinidad volumes? And maybe long or medium or long term, how do you expect this to affect supply and demand once the impacts from Iran settle down? Thank you.
Yeah, when you look at the Texas plants, there has been a long lead to their full production, and I don't think they're still at full production. And so those tons have been absorbed. They've been moving around the world. They've had some contracts, and now with Yara purchasing the Gulf Coast plant, I assume a lot of that product will go to Europe, offsetting production cutbacks. But you're correct. There have been offsets throughout the world. Trinidad is one that have taken tonnage off market. On the demand side, there's also been some negative impacts with, as you've heard from the phosphate producers, with their cutbacks due to limited supply of sulfur and sulfuric acid. That has limited phosphate production, which therefore has limited their ability to consume more ammonia. So the market has come off the highs of Q2 and is today... balanced in the $600 to $700 range depending on destinations. But we see these two plants, the Gulf Coast plant and the Woodside plant, both coming up to full production. It will be absorbed into the market.